State of the art research and development and pre-clinical and clinical trials for ProLon® were conducted at the University of Southern California’s Longevity Institute and Diabetes and Obesity Research Institute , and sponsored by the National Cancer Institutes (NCI) and National Institute on Aging (NIA) of the National Institute of Health (NIH).

The results of the above research were published in top scientific peer-reviewed journals.